Dan Wagner

Dan Wagner is a career medical device and biotechnology executive with more than 17 years of industry experience. Dan’s global experience has touched markets in over 60 countries and over a dozen healthcare specialties working with capital equipment, diagnostics, therapeutics, DME, and biologics. He has served in numerous leadership roles at Olympus Corporation, HeartSciences, Signature Biologics, and most recently as the Chief Commercial Officer at Spark Biomedical.

Throughout his career, Dan has led corporate growth objectives, defined business operations, and integrated data+strategy into a corporate cadence for success. At Otolith, Dan is spearheading Otolith’s go-to-market plan and building out Otolith’s infrastructure related to downstream operations in market access, medical affairs, sales operations, and marketing.